Radiotherapy plays a vital role in cancer treatment. In Europe alone, incidents of cancer are projected to rise around 20% by 2040, mainly due to an increasingly aging population. It’s numbers like these that emphasize the importance of pushing boundaries in radiotherapy.

With AI-optimized workflows, it’s possible to speed up treatment planning and ensure highly personalized therapies and technology like auto contouring can protect healthy organs during irradiation by means of AI. This implementation, however, is often met with challenges like staff shortages and inconsistencies with data collection, highlighting the need for more efficient implementation strategies.

In this episode, experts in the fields of radiotherapy and cancer treatment address the amazing headway being made in the world of radiotherapy as well as some of the key roles that current technology can play in the future.

Host Sasa Mutic, President of Radiation Oncology Solutions at the Varian Business Area of Siemens Healthineers, is joined by Valery Lemmens, a member of the Board of Directors at Maastro Radiotherapy Clinic in the Netherlands and creator of the Dutch Cancer Atlas; as well as Joost Verhoeff, radiation oncologist and professor of radiotherapy at Amsterdam University Medical Center; and Indrin Chetty, Vice Chair and Director of the Division of Medical Physics at Cedars-Sinai in Los Angeles.

What you’ll learn in this episode:

• By using a digital twin, medical professionals can review existing health records and continually compare that information with patient data
• With adaptive radiotherapy, radiation dosages can be tailored to circumstances like tumor size, type, and position and proximity to vital organs
• The Dutch Cancer Atlas interprets and publishes data in a context that increases awareness of regional differences in cancer incidents
• The unique role that data plays in the advancement of cancer care
• The deep troves of data that already exist within radiotherapy departments can play a key role in the integration of AI into cancer treatments
• Widespread availability of data creates the opportunity for automated treatment planning and outcome prediction

Connect with Sasa Mutic

• LinkedIn

Connect with Valery Lemmens

• LinkedIn

Connect with Joost Verhoeff

• LinkedIn

Indrin Chetty

• LinkedIn

Hosted on Acast. See acast.com/privacy for more information.

With significant disparities in diagnosis, treatment, and funding when compared to men, women’s health has long been underserved. These gaps affect not only individual health outcomes, they also have societal and economic implications which are highlighted by a recent report by the World Economic Forum and The McKinsey Health Institute which addresses a $1 trillion dollar opportunity to improve lives and economies by mitigating these disparities.

Factors like societal perception, clinical practice, and financial investment all play an important part in women’s health. Addressing the gender health gap and overcoming issues like the misdiagnosis of diseases in women, increasing women’s representation in clinical trials, and advocating for greater financial investment in women’s health are all crucial steps in building a more equal healthcare system for all.

Today, we’re joined by board members of the World Economic Forum’s Global Alliance for Women’s Health to discuss how building a more equitable healthcare system can drive meaningful change, improve healthcare for women, and create access to significant economic potential worldwide.

In this episode, host Elisabeth Staudinger, Member of the Managing Board of Siemens Healthineers, is joined by fellow World Economic Forum’s Global Alliance for Women’s Health board members Nadia Fettah, Minister of Economy and Finance for the Government of Morocco and Shyam Bishen, Head of the Centre for Health & Healthcare at the World Economic Forum.

What you’ll learn in this episode:

• Despite living longer, women spend 25% more time in poor health than men
• Women are twice as likely to be misdiagnosed after having a heart attack than men. Along with misdiagnosis and premature discharge, female cardiac patients are also less likely to be prescribed secondary prevention measures after experiencing a cardiac event
• How the Global Alliance for Women's Health is pooling together efforts in research, regulation and funding to close the gender healthcare gap
• Success stories that give hope on the path to healthcare equality

Connect with Elisabeth Staudinger

• LinkedIn

Connect with Nadia Fettah

• LinkedIn

Connect with Shyam Bishen

• LinkedIn

Hosted on Acast. See acast.com/privacy for more information.

Sepsis, originally known as blood poisoning, is a life-threatening medical emergency. Tune in to learn about the complexities of sepsis diagnosis, the role of lactate and procalcitonin levels, and the global health challenge it poses. Hear from experts and a sepsis survivor about the advancements in identifying and managing this critical condition.

Sepsis is the body’s extreme response to an infection. It occurs when a pre-existing infection triggers a chain reaction throughout a person's body. Sepsis can be difficult to diagnose because patients present different symptoms, and their observation can be subjective. According to the Global Sepsis Alliance, the disease contributes to approximately one in five deaths worldwide and in the United States alone; it stands as the leading cause of death in hospitals, leading to one in three hospital fatalities. Compounding these mortality rates is a rise in antibiotic and antimicrobial resistance due to overuse or misuse.

Today, we’re joined by experts in the field of diagnostics and critical care as well as a sepsis patient and advocate in order to more acutely understand the disease, its diagnosis, and the advancements in the field.

In this episode, host Ranga Sampath, Senior Vice President and Head of the Center for Innovation in Diagnostics at Siemens Healthineers and Member of the Board of the Sepsis Alliance, welcomes:

• Heike Spreter-Krick a sepsis survivor who is now a patient advocate working with the Global Sepsis Alliance
• Patti DeJuilio, Director of Respiratory Care and Diagnostic Services at Northwestern Medicine Central DuPage Hospital in Winfield, Illinois
• Dr. Eric Gluck, Director of Critical Care Services at Swedish Hospital and professor of medicine at Finch University of Health Sciences at The Chicago Medical School
• Mervyn Singer, professor of intensive care medicine at University College London

What you’ll learn in this episode:

• The timing of diagnosis and treatment is critical because sepsis creates oxygen deprivation in the cells.
• Risk factors like age and comorbidities can increase the likelihood of a patient developing sepsis.
• The biomarker procalcitonin can be used as an identifier for sepsis infection.
• Lactate levels, a chemical naturally produced by the body during times of stress, can be used as one indicator among others that a patient may be experiencing sepsis.
• In the UK, the National Early Warning Score helps closely monitor patients at risk for developing sepsis.
• IV antibiotics have long been the gold standard for sepsis treatment, but they are at risk of overuse and misuse.
• For many patients, surviving a sepsis infection is just the beginning of a long road to recovery.

Connect with Ranga Sampath

• LinkedIn

Connect with Heike Spreter-Krick

• Instagram

Connect with Patti DeJuilio

• LinkedIn

Connect with Mervyn Singer

• LinkedIn

Hosted on Acast. See acast.com/privacy for more information.